Evidence map›Paper›PMID 41122198›Full record

ArticleMediterranean journal of rheumatology2025

Sjögren's Syndrome is Rare in Psoriasis, but Common in Psoriatic Arthritis: Two Sides of a Coin - A Single Centre Retrospective Study.

Kerem Abacar, Şeyma Çolakoğlu-Özkaya, Tülin Ergun, Alida Aliyeva, Seda Kutluğ-Ağaçkiran, Gizem Sevik, Seher Küçükoğlu-Cesur, Mehmet Soy, Pamir Atagündüz

Abstract read
In one paragraph

Article in Mediterranean journal of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kerem AbacarDivision of Rheumatology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Şeyma Çolakoğlu-ÖzkayaDepartment of Medical Biology and Genetics, Institute of Health Sciences, Marmara University, Istanbul, Turkey.
Tülin ErgunDepartment of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
Alida AliyevaDivision of Rheumatology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Seda Kutluğ-AğaçkiranDivision of Rheumatology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Gizem SevikDivision of Rheumatology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Seher Küçükoğlu-CesurDepartment of Dermatology, School of Medicine, Altinbaş University, Istanbul, Turkey.
Mehmet SoyDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Altinbas University, Istanbul, Turkey.
Pamir AtagündüzDivision of Rheumatology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sjögren's syndrome (SS) may accompany psoriatic arthritis (PsA), if ever, and its presence during psoriasis (PsO) is rare. Recent observations of an association with predominantly axial forms of PsA are intriguing. Whether SS complicates PsO and PsA to the same extent is not known. Objectives: To investigate the frequency of SS in patients with PsO and PsA, and elucidate disease features associated with SS. Methods: In this retrospective analysis, we collected the data about previously recorded in the follow-up files of PsO and PsA patients. We classified patients who met the 2002 American-European Sjögren's syndrome Consensus Group Criteria (AECG) or the 2016 ACR-EULAR Classification Criteria for primary Sjögren's Syndrome as SS. Frequency rates of SS in PsA patients and in PsO patients without arthritis were compared and SS characteristics were described. Results: Of the 184 PsO patients, 112 had PsA and 72 PsO alone. A substantial proportion of PsA patients had SS. This association was not present in the PsO group (PsA: 20(%17.9), PsO: 0(%0), p<0.001). Gender distribution, mean age, and PsO onset age were similar in both. Symmetric polyarticular involvement was rare, and most PsO patients with arthritis were ANA positive at a serum dilution level of 1:320 and beyond. Conclusions: SS seems to be part of the clinical picture in a substantial proportion of PsA patients, and its absence in PsO implies that SS may be arthritis associated. Whether the type of arthritis is critical in developing SS in PsA deserves further studies with large populations.

Indexed as

anti-nuclear antibodyaxial spondyloarthritispsoriasispsoriatic arthritissicca symptomsSjögren’s syndrome

Identifiers

PMID41122198
PMCPMC12536734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.